Cabaletta Bio

-$0.02 (-1.56%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.

About CABA

Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.

CEO
Steven Nichtberger
Employees
54
Headquarters
Philadelphia, Pennsylvania
Founded
2017

CABA Key Statistics

Market cap
36.51M
Price-Earnings ratio
—
Dividend yield
—
Average volume
137.74K
High today
$1.32
Low today
$1.26
Open price
$1.27
Volume
82.82K
52 Week high
$14.95
52 Week low
$1.17

CABA Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.60 per share
Actual
-$0.45 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure